These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 34777799)

  • 1. Prognostic significance of the number of removed lymph nodes according to FIGO stage in ovarian clear cell carcinoma.
    Tamura K; Takei Y; Matsubara S; Takahashi S; Taneichi A; Takahashi Y; Yoshiba T; Koyanagi T; Saga Y; Fujiwara H
    Mol Clin Oncol; 2021 Dec; 15(6):263. PubMed ID: 34777799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ovarian clear cell carcinoma with or without endometriosis origin in a single institution cohort.
    Sun M; Jiang W
    Discov Oncol; 2023 Apr; 14(1):39. PubMed ID: 37004660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and prognostic impact of lymphadenectomy and lymph node metastasis in clinically early-stage ovarian clear cell carcinoma.
    Mahdi H; Moslemi-Kebria M; Levinson KL; Gojayev A; Lockhart D; Ali-Fehmi R; Munkarah AR
    Int J Gynecol Cancer; 2013 Sep; 23(7):1226-30. PubMed ID: 23736258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of lymph nodes ratio in patients with stage III ovarian clear cell carcinoma: A retrospective study of patients in Southwest China.
    Nie D; Mao X; Li Z
    J Cancer; 2019; 10(19):4689-4694. PubMed ID: 31528234
    [No Abstract]   [Full Text] [Related]  

  • 5. Residual Tumor Diameter Predicts Progression After Primary Debulking Surgery of Ovarian Clear Cell Carcinoma (OCCC): Clinicopathologic Study of Stage II-IV OCCC Patients from a Single Institution.
    Shi Y; Dai M; Zhang Y; Qi Y; Li Z; Cai H
    Cancer Manag Res; 2021; 13():2215-2222. PubMed ID: 33692636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of the number of removed lymph nodes on recurrence-free survival in stage I ovarian clear cell carcinoma.
    Takei Y; Takahashi S; Machida S; Taneichi A; Yoshiba T; Takahashi Y; Yoshida C; Saga Y; Matsubara S; Fujiwara H
    Int J Clin Oncol; 2018 Oct; 23(5):930-935. PubMed ID: 29679177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical characteristics and prognosis of ovarian clear cell carcinoma: a 10-year retrospective study.
    Zhu C; Zhu J; Qian L; Liu H; Shen Z; Wu D; Zhao W; Xiao W; Zhou Y
    BMC Cancer; 2021 Mar; 21(1):322. PubMed ID: 33766002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymph Node Involvement Pattern and Survival Differences of FIGO IIIC and FIGO IIIA1 Ovarian Cancer Patients After Primary Complete Tumor Debulking Surgery: A 10-Year Retrospective Analysis of the Tumor Bank Ovarian Cancer Network.
    Gasimli K; Braicu EI; Nassir M; Richter R; Babayeva A; Chekerov R; Darb-Esfahani S; Sehouli J; Muallem MZ
    Ann Surg Oncol; 2016 Apr; 23(4):1279-86. PubMed ID: 26832880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endometriosis does not confer improved prognosis in ovarian clear cell carcinoma: a retrospective study at a single institute.
    Zhao T; Shao Y; Liu Y; Wang X; Guan L; Lu Y
    J Ovarian Res; 2018 Jun; 11(1):53. PubMed ID: 29941051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Number of Removed Pelvic Lymph Nodes as a Prognostic Marker in FIGO Stage IB1 Cervical Cancer with Negative Lymph Nodes.
    Wang R; Tao X; Wu X; Jiang H; Xia H
    J Minim Invasive Gynecol; 2020; 27(4):946-952. PubMed ID: 31394263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Friend or foe? The prognostic role of endometriosis in women with clear cell ovarian carcinoma. A UK population-based cohort study.
    Tranoulis A; Buruiana FH; Gupta B; Kwong A; Lakhiani A; Yap J; Balega J; Singh K
    Arch Gynecol Obstet; 2022 May; 305(5):1279-1289. PubMed ID: 34468823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of preoperative lymphocyte-monocyte ratio in patients with ovarian clear cell carcinoma.
    Kwon BS; Jeong DH; Byun JM; Lee TH; Choi KU; Song YJ; Suh DS; Kim KH
    J Cancer; 2018; 9(7):1127-1134. PubMed ID: 29675093
    [No Abstract]   [Full Text] [Related]  

  • 13. Therapeutic significance of full lymphadenectomy in early-stage ovarian clear cell carcinoma.
    Yamazaki H; Todo Y; Shimada C; Takeshita S; Minobe S; Okamoto K; Yamashiro K; Kato H
    J Gynecol Oncol; 2018 Mar; 29(2):e19. PubMed ID: 29400012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endometriosis-associated ovarian cancer is not a distinct clinical entity among young patients: A 12-year cohort study.
    Cai Y; Yin J; Jin Y; Li Y; Wu M; Yang J; Huang H; Leng J; Pan L
    Eur J Surg Oncol; 2020 May; 46(5):876-882. PubMed ID: 31837932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for patients with pelvic lymph node metastases following radical cystectomy with en bloc pelvic lymphadenectomy: concept of lymph node density.
    Stein JP; Cai J; Groshen S; Skinner DG
    J Urol; 2003 Jul; 170(1):35-41. PubMed ID: 12796639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and significance of ARID1A mRNA in endometriosis- associated ovarian cancer.
    Wang Q; Wang L; L Y; Ding X; Liu A
    J BUON; 2017; 22(5):1314-1321. PubMed ID: 29135119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Twenty-eight months progression-free survival after pyrotinib therapy for HER2-positive recurrent ovarian clear cell carcinoma: a case report.
    Wu J; You Y; Zhuang R; Guo X; Zhang C; Zhang Q; Zhou Y; Li Q
    Ann Transl Med; 2022 Mar; 10(6):387. PubMed ID: 35433993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The surgical, histopathological characteristics, and survival outcome of ovarian clear cell carcinoma: a retrospective case series sharing the experience of a tertiary cancer centre.
    El Tawab S; Nistor S; Roux R; Manek S; Gaitskell K; Ahmed AA; Kehoe S; Soleymani Majd H
    Transl Cancer Res; 2024 Sep; 13(9):5037-5049. PubMed ID: 39430857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival outcome of stage I ovarian clear cell carcinoma with lympho-vascular space invasion.
    Matsuo K; Yoshino K; Hasegawa K; Murakami R; Ikeda Y; Adachi S; Hiramatsu K; Yokoyama T; Nishimura M; Sheridan TB; Enomoto T; Fujiwara K; Matsumura N; Konishi I; Fotopoulou C; Roman LD; Sood AK
    Gynecol Oncol; 2015 Feb; 136(2):198-204. PubMed ID: 25497604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Axillary lymph node ratio and total number of removed lymph nodes: predictors of survival in stage I and II breast cancer.
    van der Wal BC; Butzelaar RM; van der Meij S; Boermeester MA
    Eur J Surg Oncol; 2002 Aug; 28(5):481-9. PubMed ID: 12217299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.